EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC-ND 4.0

Theoretical considerations and empirical predictions of the pharmaco- and population dynamics of heteroresistance

Bruce R Levin iD, Brandon A Berryhill iD, Teresa Gil-Gil iD, Joshua A Manuel iD, Andrew P Smith, Jacob E Choby iD, Dan I Andersson iD, David S Weiss, Fernando Baquero iD

Proceedings of the National Academy of Sciences · 16.04.2024 · 121 (16)

DOI: 10.1073/pnas.2318600121 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Proceedings of the National Academy of Sciences, online erschienen am 08.04.2024. Verfasst von Bruce R Levin und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Biology, Emory University, Atlanta, GA 30322. Hauptthemen laut MEDLINE: Anti-Bacterial Agents. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 34 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIAID NIH HHS, NIGMS NIH HHS, HHS | NIH | National Institute of General Medical Sciences.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Antibiotics are considered one of the most important contributions to clinical medicine in the last century. Due to the use and overuse of these drugs, there have been increasing frequencies of infections with resistant pathogens. One form of resistance, heteroresistance, is particularly problematic; pathogens appear sensitive to a drug by common susceptibility tests. However, upon exposure to the antibiotic, resistance rapidly ascends, and treatment fails. To quantitatively explore the processes contributing to the emergence and ascent of resistance during treatment and the waning of resistance following cessation of treatment, we develop two distinct mathematical and computer-simulation models of heteroresistance. In our analysis of the properties of these models, we consider the factors that determine the response to antibiotic-mediated selection. In one model, heteroresistance is progressive, with each resistant state sequentially generating a higher resistance level. In the other model, heteroresistance is non-progressive, with a susceptible population directly generating populations with different resistance levels. The conditions where resistance will ascend in the progressive model are narrower than those of the non-progressive model. The rates of reversion from the resistant to the sensitive states are critically dependent on the transition rates and the fitness cost of resistance. Our results demonstrate that the standard test used to identify heteroresistance is insufficient. The predictions of our models are consistent with empirical results. Our results demand a reevaluation of the definition and criteria employed to identify heteroresistance. We recommend that the definition of heteroresistance should include a consideration of the rate of return to susceptibility.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Anti-Bacterial AgentsPopulation DynamicsMicrobial Sensitivity Tests

Stichwörter der Autor:innen

antibiotic resistanceheteroresistancemathematical modelingmicrobiologypharmacodynamics

Substanzen

Anti-Bacterial Agents

Autor:innen und Institutionen

  • Department of Biology, Emory University, Atlanta, GA 30322.
  • Emory Antibiotic Resistance Center, Atlanta, GA 30322.
  • Program in Microbiology and Molecular Genetics, Graduate Division of Biological and Biomedical Sciences, Laney Graduate School, Emory University, Atlanta, GA 30322.
  • Emory Vaccine Center, Atlanta, GA 30322.
  • Department of Medical Biochemistry and Microbiology, Uppsala University, Uppsala SE-75123, Sweden.
  • Division of Infectious Diseases, Department of Medicine, Emory University School of Medicine, Atlanta, GA 30322.

ORCID-Profile: Bruce R Levin, Brandon A Berryhill, Teresa Gil-Gil, Joshua A Manuel, Jacob E Choby, Dan I Andersson, Fernando Baquero

Förderung

  • NIAID NIH HHS
  • NIGMS NIH HHS
  • HHS | NIH | National Institute of General Medical Sciences
  • HHS | NIH | NIAID | Division of Intramural Research
  • MEC | Instituto de Salud Carlos III

Zitieren

APA

Levin, B. R., Berryhill, B. A., Gil-Gil, T., Manuel, J. A., Smith, A. P., Choby, J. E., Andersson, D. I., Weiss, D. S., & Baquero, F. (2024). Theoretical considerations and empirical predictions of the pharmaco- and population dynamics of heteroresistance. Proceedings of the National Academy of Sciences, 121(16). https://doi.org/10.1073/pnas.2318600121

Vancouver

Levin BR, Berryhill BA, Gil-Gil T, Manuel JA, Smith AP, Choby JE, et al. Theoretical considerations and empirical predictions of the pharmaco- and population dynamics of heteroresistance. Proceedings of the National Academy of Sciences. 2024;121(16). doi:10.1073/pnas.2318600121

BibTeX
@article{Levin2024,
  author = {Levin, Bruce R and Berryhill, Brandon A and Gil-Gil, Teresa and Manuel, Joshua A and Smith, Andrew P and Choby, Jacob E and Andersson, Dan I and Weiss, David S and Baquero, Fernando},
  title = {Theoretical considerations and empirical predictions of the pharmaco- and population dynamics of heteroresistance},
  journal = {Proceedings of the National Academy of Sciences},
  year = {2024},
  volume = {121},
  number = {16},
  doi = {10.1073/pnas.2318600121}
}
Kostenlos starten →